Riskpilot← Back to searchSign inGet full accessENDOSTOS Aktiebolag
ABActiveOrg 5563339208Strandvägen 9Dental practice care activities · NACE 8623Est. 19880 employees
Revenue 2024
SEK 0
EBITDA margin
—
-17% vs 2023
Equity ratio
51.4%
Financial strength
Net profit 2024
SEK 727K
-58% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -321K | -17% |
| Net profit | SEK 727K | -58% |
| Total assets | SEK 6M | -3% |
| Equity | SEK 3,1M | -8% |
| Employees | 0 | — |
Legal name
ENDOSTOS Aktiebolag
Org number
5563339208
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
5 oktober 1988
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolagets verksamhet är att bedriva tandvård samt utbildning, kursverksamhet och konsultverksamhet inom samma område, förvaltning av värdepapper och fast egendom och därmed förenlig verksamhet.
Address
Strandvägen 9
Phone
+46705124245
Email
asa_lindahl66@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 620 | 27 | 47 | 105 | 0 |
| Staff expenses | — | — | −7 | — | — |
| EBITDA | −685 | −2 366 | −340 | −275 | −321 |
| Depreciation & amort. | −77 | −97 | −13 | −0 | −0 |
| EBIT | −762 | −2 463 | −353 | −275 | −321 |
| Net financials | 199 | −4 537 | 11 | 9 | −28 |
| Profit before tax | 2 384 | −1 752 | 57 | 1 717 | 727 |
| Tax | −520 | −202 | −22 | −0 | −0 |
| Net profit | 1 864 | −1 954 | 36 | 1 717 | 727 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 7 403 | 7 055 | 6 677 | 6 199 | 5 997 |
| Equity | 4 059 | 4 355 | 3 641 | 3 359 | 3 085 |
| Long-term debt | 0 | 0 | — | 0 | 0 |
| Short-term debt | 213 | 262 | 999 | 1 136 | 1 808 |
| Total debt | 213 | 262 | 999 | 1 136 | 1 808 |
EBITDA margin
-32100000.0%
This company
15.8%
Market median
-203164657% vs market
20202024
Equity ratio
51.4%
This company
38.2%
Market median
+35% vs market
20202024
Return on equity
23.6%
This company
18.4%
Market median
+28% vs market
20202024
Net profit margin
72700000.0%
This company
8.1%
Market median
+897530764% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.94×
This company
0.62×
Market median
+52% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JM | Audit | 2022 |
| Former (1) | ||
TM | Audit | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2020 | |
| Deputy Board Member | 2025 | |
| Board of Directors | 2020 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AalMo Holding AB
ENDOSTOS Aktiebolag Board members of ENDOSTOS Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jonas Mikael Edvinsson | Audit | 0 companies |
| Tommy Morgan Claesson | Audit | 0 companies |
| Lars Morgan Olsson | Chairman | 0 companies |
| Hampus Carl Erik Lindahl Nielsen | Deputy Board Member | 0 companies |
| Sara Jenny Marie Jürisoo | Deputy Board Member | 0 companies |
| Åsa Lindahl | Board of Directors | 0 companies |